Seminars and Events

Preliminary Schedule

Details

20th November

• Lunch from 12pm
• Conference Welcome
• Talk Session 1
• Afternoon tea
• Talk Session 2
• Evening Networking Function (5.30-8.30pm, includes drink service and nibbles)

21st November

• Breakfast from 7am if staying on-site
• Optional early morning kayak
• Talk session 3
• Morning tea
• Talk session 4
• Lunch
• Talk session 5 + 6
• Afternoon Tea
• Poster viewing session (5-6.30pm, includes drink service & nibbles)

Dinner bookings can be made onsite for Boilerhouse Restaurant, pop into Engine Room Bar or book a “Ghosty Dine” package with Q Station.

22nd November

• Breakfast from 7am if staying on-site
• Talk session 8
• Morning Tea
• Talk session 9
• Lunch
• Awards & Conference close early afternoon (TBC)

Type

Early-bird registration (before 15/8/2019)

Regular registration (16/8/2019-31/10/2019)

Bookings Link

Standard

Junior post-doc <10 yrs since PhD

Student

Single day

Trade exhibitor/sponsor

   >  ACCOMMODATION OPTIONS & BOOKINGS

> HOW TO GET TO Q STATION

2019 Conference Themes

Analysis of rare variants, Mendelian traits and families

Biobank studies

GWAS

Gene expression & functional genomics

Population genetics

 Translation into clinical practice

       >  SUBMIT ABSTRACT

INTERNATIONAL SPEAKERS

Cathryn Lewis, King’s College London, UK

Michael Boehnke is the Richard G. Cornell Distinguished University Professor of Biostatistics and Director of the University of Michigan Center for Statistical Genetics and Genome Science Training Program. Dr. Boehnke’s research focuses on problems of study design and statistical analysis of human genetic data with a particular emphasis on development and application of statistical methods for human gene mapping, with a current focus on disease and trait association studies based on genome sequence and genotype-array data. He is principal investigator of the Finland-United States Investigation of NIDDM (FUSION) study of the genetics of type 2 diabetes, the GoT2D and T2D-GENES type 2 diabetes sequencing studies, and the BRIDGES and InPSYght sequencing studies of bipolar disorder and schizophrenia.

Cornelia M van Duijn is Professor of Epidemiology at the Nuffield Department of Population Health at The University of Oxford, UK.  She is based at the Oxford Big Data Institute where she integrates large-scale (epi)genetic, transcriptomic, proteomic, metabolomic and microbiome data of epidemiological cohorts with that of brain imaging and cellular models. Cornelia’s research focuses on brain and ocular diseases such as Alzheimer disease and glaucoma but her interest spans systemic vascular, endocrine and gastrointestinal pathology that is relevant for brain and ocular function. Before moving to Oxford, Cornelia was head of Genetic Epidemiology of the Erasmus University Medical Centre and director of the international education and training program in genetic epidemiology. In 2016, she was co-appointed at the Leiden Academic Center for Drug Research (LACDR) as a Professor of Translational Epidemiology.

NATIONAL SPEAKERS

Stephen Leslie, University of Melbourne

Associate Professor Stephen Leslie is a statistician working in the field of mathematical genetics.  He obtained his doctorate from the Department of Statistics, University of Oxford in 2008.  After graduating Stephen was a post-doctoral researcher in the Department of Statistics at Oxford.  He was awarded one of Oxford’s prestigious Nuffield Department of Medicine Scientific Leadership Fellowships.  In 2012 Stephen returned to Australia to establish his own research group.  Since 2016 Stephen has been Associate Professor of Statistical Genomics at the University of Melbourne.  In 2016 Stephen was awarded the Woodward Medal by the University of Melbourne, the University’s highest award for research by faculty. In 2019 Stephen was awarded the Moran Medal of the Australian Academy of Science.

Stephen’s work covers several aspects of statistical and population genetics.  His main interests are in detecting and controlling for population differences in genetic data; typing complex genetic variation, with a particular focus on immune-associated loci; and performing statistically rigorous analyses of the relationship of genetic variants to disease.

Professor Sarah Medland is a statistical geneticist working on mental health and neurological traits. She received her PhD in 2006 from the University of Queensland, followed by a Sidney Sax NHMRC Post-doctoral Fellowship at the Virginia Institute of Psychiatric and Behavioral Genetics in USA. She is currently the coordinator of the mental health research program and head of the psychiatric genetics group at QIMR Berghofer Medical Research Institute. As chair of the genetics team of ENIGMA neuro-imaging genetics consortium, Sarah has played a leading role in large multi-site studies identifying genetic variants influencing brain structure in healthy and disease-focused cohorts. She is also the PI of nation-wide studies recruiting large cohorts of individuals diagnosed with ADHD, ASD, Bipolar, Depression and Schizophrenia which are seeking to identify genetic variants associated with developing these disorders and variation in treatment response.

Laureate Professor Ingrid Scheffer AO MBBS PhD FAA FAHMS is a physician-scientist whose work as a paediatric neurologist and epileptologist at the University of Melbourne and the Florey Institute has led the field of epilepsy genetics over more than 25 years, in collaboration with Professor Samuel Berkovic and molecular geneticists. This resulted in identification of the first epilepsy gene and many genes subsequently. Her major interests are in the genetics of the epilepsies, epilepsy syndromology and classification, and translational research. She collaborates on research on the genetics of speech and language disorders, autism spectrum disorders, cortical malformations and intellectual disability. She led the first major reclassification of the epilepsies in 28 years, published in March 2017, for the International League Against Epilepsy. In 2014, she was elected as a Fellow of the Australian Academy of Science and also as Vice-President and Foundation Fellow of the Australian Academy of Health and Medical Sciences. She was a co-recipient of the 2014 Prime Minister’s Prize for Science. In 2018 she was elected to the Royal Society (London).

A/Professor Tony Roscioli is a clinical geneticist at Sydney Children’s Hospital, senior staff specialist in genomic pathology at NSWHEALTH pathology Randwick, and Group leader in Neurogenomics at NeuRA, University of New South Wales. His research interests in gene identification, with a focus on disorders of neuronal migration, intellectual disability (ID) and craniosynostosis/orofacial clefting, have stemmed from clinical training in the field of developmental anomalies/congenital malformations. A/Prof Roscioli was awarded an NHMRC Overseas Biomedical Postdoctoral Fellowship, taking him to Radboud University Nijmegen Medical Centre in The Netherlands, where he received valuable training in genomic medicine. Gene identification has subsequently been a major research emphasis, culminating in 24 disease gene identifications and 6 Nature Genetics papers. He has worked in translational genomics in Sydney since 2012, guiding two laboratories to clinical accreditation, designing practical genomic consent forms, and co-ordinating genomic education for professionals. He was recently awarded a fellowship of the UK College of Pathologists and leads a Centre of Research Excellence and Australian Genomics Health Alliance flagship in neurocognitive disorders as well as the SPHERE initiative, GenomeConnect.